39
Participants
Start Date
June 1, 2022
Primary Completion Date
June 1, 2025
Study Completion Date
January 1, 2026
avatrombopag
Avatrombopag, 40-60 mg (body weight \< 80 kg, 40 mg per day; body weight \> 80 kg, 60 mg per day) orally once daily for at least 3 months and followed up for 3 months to determine hematological response and evaluate the drug security.
RECRUITING
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin
Peking University People's Hospital
OTHER
Xiyuan Hospital of China Academy of Chinese Medical Sciences
OTHER
Second Hospital of Shanxi Medical University
OTHER
First Affiliated Hospital of Harbin Medical University
OTHER
The First Hospital of Hebei Medical University
OTHER
Institute of Hematology & Blood Diseases Hospital, China
OTHER